Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | F2R | P25116 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19559575 | 0.91 | GAA (0.52) | GAATP53ALDH1A1KMT2AMEN1 | |
| SCHEMBL15020959 | 0.86 | GAA (0.55) | GAAALDH1A1POLBNPC1RAB9A | |
| SCHEMBL12836916 | 0.86 | GAA (0.55) | GAAALDH1A1POLBNPC1RAB9A | |
| SCHEMBL29141123 | 0.85 | KMT2A (0.56) | GAAALDH1A1KMT2AMEN1HPGD | |
| SCHEMBL9165207 | 0.83 | SOAT2 (0.55) | GAAALDH1A1KMT2AMEN1POLB | |
| SCHEMBL11221078 | 0.83 | SMN1; SMN2 (0.64) | ALDH1A1KMT2AMEN1HPGDMAPT | |
| SCHEMBL21998926 | 0.83 | SOAT2 (0.55) | GAAALDH1A1KMT2AMEN1POLB | |
| SCHEMBL21998908 | 0.83 | SOAT2 (0.55) | GAAALDH1A1KMT2AMEN1POLB | |
| SCHEMBL1819402 | 0.82 | KDM4E (0.61) | GAATP53ALDH1A1KMT2AMEN1 | |
| SCHEMBL265614 | 0.81 | TP53 (0.70) | TP53ALDH1A1HPGDMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2316819-B1 | Self-assembled nanostructures | XEROX CORP (US) | 2017-11-08 | — | — | EP | disclosed |
| EP-2316819-B1 | Self-assembled nanostructures | XEROX CORP (US) | 2017-11-08 | — | — | EP | disclosed |
| US-8703988-B2 | Self-assembled nanostructures | XEROX CORPORATION (US) | 2014-04-22 | — | — | US | disclosed |
| US-8703988-B2 | Self-assembled nanostructures | XEROX CORPORATION (US) | 2014-04-22 | — | — | US | disclosed |
| US-8703988-B2 | Self-assembled nanostructures | XEROX CORPORATION (US) | 2014-04-22 | — | — | US | disclosed |
| US-20110311813-A1 | SELF-ASSEMBLED NANOSTRUCTURES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2011-12-22 | — | — | US | disclosed |
| US-20110311813-A1 | SELF-ASSEMBLED NANOSTRUCTURES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2011-12-22 | — | — | US | disclosed |
| US-20110311813-A1 | SELF-ASSEMBLED NANOSTRUCTURES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2011-12-22 | — | — | US | disclosed |
| EP-2316819-A2 | Self-assembled nanostructures | Xerox Corporation (US) | 2011-05-04 | — | — | EP | disclosed |
| EP-2316819-A2 | Self-assembled nanostructures | Xerox Corporation (US) | 2011-05-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110311813-A1 | SELF-ASSEMBLED NANOSTRUCTURES | ARG1, H1-3, H1-4 | GAA 2654/4885TP53 992/4885ALDH1A1 1868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.